A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancer. [electronic resource]
Producer: 20070327Description: 84-9 p. digitalISSN:- 1040-8428
- Adult
- Age Factors
- Aged
- Breast Neoplasms -- complications
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Comorbidity
- Dose-Response Relationship, Drug
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Drug Evaluation
- Humans
- Middle Aged
- Neoplasm Metastasis
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.